Thermo Fisher Scientific to acquire all outstanding shares of Dionex for $118.50

Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, is confident in being able to secure all necessary outstanding regulatory and antitrust approvals in connection with its previously announced tender offer to acquire all of the outstanding shares of Dionex Corporation (NASDAQ: DNEX) for $118.50 per share in cash.

Thermo Fisher expects to consummate the tender offer promptly after its expiration, scheduled for 7:00 p.m., New York City time, on Friday, May 13, 2011, subject to receipt of these approvals. Consummation of the tender offer also assumes that at least a majority of the outstanding shares of Dionex common stock, on a fully diluted basis, have been tendered and not withdrawn prior to the expiration of the offer and that other standard closing conditions have been satisfied.

Source:

Thermo Fisher Scientific

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2019, June 18). Thermo Fisher Scientific to acquire all outstanding shares of Dionex for $118.50. News-Medical. Retrieved on October 18, 2019 from https://www.news-medical.net/news/20110511/Thermo-Fisher-Scientific-to-acquire-all-outstanding-shares-of-Dionex-for-2411850.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific to acquire all outstanding shares of Dionex for $118.50". News-Medical. 18 October 2019. <https://www.news-medical.net/news/20110511/Thermo-Fisher-Scientific-to-acquire-all-outstanding-shares-of-Dionex-for-2411850.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific to acquire all outstanding shares of Dionex for $118.50". News-Medical. https://www.news-medical.net/news/20110511/Thermo-Fisher-Scientific-to-acquire-all-outstanding-shares-of-Dionex-for-2411850.aspx. (accessed October 18, 2019).

  • Harvard

    Thermo Fisher Scientific Inc.. 2019. Thermo Fisher Scientific to acquire all outstanding shares of Dionex for $118.50. News-Medical, viewed 18 October 2019, https://www.news-medical.net/news/20110511/Thermo-Fisher-Scientific-to-acquire-all-outstanding-shares-of-Dionex-for-2411850.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Thermo Fisher Scientific collaborates with CGT Catapult to create seamless cell and gene therapy supply chain